RE: In auction19 May 2026 08:10
Lyn Rees, Chief Executive Officer of Novacyt, commented: "We are pleased to have launched the Yourgene® Insight DPYD assay on schedule, enabling a streamlined, cost-effective pharmacogenetic workflow that supports safer, more personalised treatment decisions for cancer patients at risk of suffering a severe, and potentially life-threatening reaction to common chemotherapy